There has been a new antidepressant on the market every two or three years. In 1987, the antidepressant fluoxetine (Prozac) was introduced. It had been tested by the FDA and found to be an ...

In 2022/23, 86 million antidepressants were prescribed to an estimated 8.6 million patients in England, NHS figures show. In the new research, the most commonly used antidepressants in the UK were ...

Its appeal follows a recent report commissioned by the Department of Transport which found that more research was needed into the effects of newer antidepressants on driving performance and ...

Johnson & Johnson's Spravato therapy for treatment-resistant depression (TRD) hasn't made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate ...

The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine for potentially cancer-causing chemicals in the medication.

The purpose of this study was to find ways to facilitate formulary decisions by an MCO regarding selection of antidepressants for the treatment of major depressive disorders. To accomplish this ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

Sexual side effects have emerged as a major clinical concern with many of the newer antidepressants. Approximately 30% to 40% of patients on serotonergic antidepressants experience sexual dysfunction.

Thousands of bottles of the antidepressant duloxetine, which is the generic version of Cymbalta, have been recalled due to the presence of a toxic chemical, according to a notice from the Food and ...